152 related articles for article (PubMed ID: 36004481)
21. Circular
Zou C; Li X; Wei H; Wu S; Song J; Tang Z; Luo H; Lv X; Ai Y
Bioengineered; 2022 Apr; 13(4):11012-11025. PubMed ID: 35481460
[TBL] [Abstract][Full Text] [Related]
22. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.
Li M; Yu D; Li Z; Zhao C; Su C; Ning J
Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645
[TBL] [Abstract][Full Text] [Related]
23. Interferon γ suppresses dentin sialophosphoprotein in oral squamous cell carcinoma cells resulting in antitumor effects, via modulation of the endoplasmic reticulum response.
Gkouveris I; Nikitakis NG; Aseervatham J; Ogbureke KUE
Int J Oncol; 2018 Dec; 53(6):2423-2432. PubMed ID: 30320380
[TBL] [Abstract][Full Text] [Related]
24. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
26. Methyltransferase-like 3-induced N6-methyladenosine upregulation promotes oral squamous cell carcinoma by through p38.
Xu T; Zhang W; Chai L; Liu C; Zhang S; Xu T
Oral Dis; 2023 Mar; 29(2):639-648. PubMed ID: 34479400
[TBL] [Abstract][Full Text] [Related]
27. Methylated RNA Immunoprecipitation Sequencing Reveals the m
Wang X; Wu J; Zhang L; Zhao W; Deng J
J Immunol Res; 2022; 2022():7277583. PubMed ID: 35874897
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
[TBL] [Abstract][Full Text] [Related]
29. Metformin inhibits oral squamous cell carcinoma progression through regulating RNA alternative splicing.
Ji M; Lv Y; Chen C; Xing D; Zhou C; Zhao J; Qi Y; Zhang J; Wang Y; Ma X; Xu W; Zhang W; Li X
Life Sci; 2023 Feb; 315():121274. PubMed ID: 36509195
[TBL] [Abstract][Full Text] [Related]
30. Stromal cells in the tumor microenvironment promote the progression of oral squamous cell carcinoma.
Shan Q; Takabatake K; Omori H; Kawai H; Oo MW; Nakano K; Ibaragi S; Sasaki A; Nagatsuka H
Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34368860
[TBL] [Abstract][Full Text] [Related]
31. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma.
Kong XP; Yao J; Luo W; Feng FK; Ma JT; Ren YP; Wang DL; Bu RF
Mol Cell Biochem; 2014 Sep; 394(1-2):177-86. PubMed ID: 24889262
[TBL] [Abstract][Full Text] [Related]
32. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
34. Splice site m
Li X; Fang J; Tao X; Xia J; Cheng B; Wang Y
PeerJ; 2023; 11():e14824. PubMed ID: 36811004
[TBL] [Abstract][Full Text] [Related]
35. A γ-Secretase Inhibitor Attenuates Cell Cycle Progression and Invasion in Human Oral Squamous Cell Carcinoma: An In Vitro Study.
Pongjantarasatian S; Nowwarote N; Rotchanakitamnuai V; Srirodjanakul W; Saehun R; Janebodin K; Manokawinchoke J; Fournier BPJ; Osathanon T
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012128
[TBL] [Abstract][Full Text] [Related]
36. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1.
Gao Z; Zhang Y; Zhou H; Lv J
Int J Oncol; 2020 Jan; 56(1):273-282. PubMed ID: 31746368
[TBL] [Abstract][Full Text] [Related]
37. [The role of chemokine receptor CXCR4 and its ligand CXCL12 in the process of proliferation and migration of oral squamous cell carcinoma].
Yin D; Zhang Z; Gao S; Li B
Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Feb; 31(1):8-12. PubMed ID: 23484292
[TBL] [Abstract][Full Text] [Related]
38. PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.
Bhol CS; Mishra SR; Patil S; Sahu SK; Kirtana R; Manna S; Shanmugam MK; Sethi G; Patra SK; Bhutia SK
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166428. PubMed ID: 35533906
[TBL] [Abstract][Full Text] [Related]
39. Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro.
Ying XJ; Jin B; Chen XW; Xie J; Xu HM; Dong P
Biomed Res Int; 2015; 2015():150390. PubMed ID: 25811021
[TBL] [Abstract][Full Text] [Related]
40. Icaritin induces mitochondrial apoptosis by up-regulating miR-124 in human oral squamous cell carcinoma cells.
Jin L; Miao J; Liu Y; Li X; Jie Y; Niu Q; Han X
Biomed Pharmacother; 2017 Jan; 85():287-295. PubMed ID: 27889233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
